» Articles » PMID: 23299521

Long-term Survival Analysis of Pure Laparoscopic Versus Open Hepatectomy for Hepatocellular Carcinoma in Patients with Cirrhosis: a Single-center Experience

Overview
Journal Ann Surg
Specialty General Surgery
Date 2013 Jan 10
PMID 23299521
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Laparoscopic liver resection has been reported as a safe and effective approach to the management of liver cancer. However, studies of long-term outcomes regarding tumor recurrence and patient survival in comparison with the conventional open approach are limited. The aim of this study was to analyze the survival outcome of laparoscopic liver resection versus open liver resection.

Patients And Methods: Between October 2002 and September 2009, 32 patients underwent pure laparoscopic liver resection for hepatocellular carcinoma (HCC). Case-matched control patients (n = 64) who received open liver resection for HCC were included for comparison. Patients were matched in terms of cancer stage, tumor size, location of tumor, and magnitude of resection. Immediate operation outcomes, operation morbidity, disease-free survival, and overall survival were compared between groups.

Results: With the laparoscopic group compared with the open resection group, operation time was 232.5 minutes versus 204.5 minutes (P = 0.938), blood loss was 150 mL versus 300 mL (P = 0.001), hospital stay was 4 days versus 7 days (P < 0.0001), postoperative complication was 2 (6.3%) versus 12 (18.8%) (P = 0.184), disease-free survival was 78.5 months versus 29 months (P = 0.086), and overall survival was 92 months versus 71 months (P = 0.142). The disease-free survival for stage II HCC was 22.1 months versus 12.4 months (P = 0.075).

Conclusions: Laparoscopic liver resection for HCC is associated with less blood loss, shorter hospital stay, and fewer postoperative complications in selected patients with no compromise in survival.

Citing Articles

Immunotherapy and liver cancer research trends and the 100 most cited articles: A bibliometric analysis.

Kong Y, Wang Y, Yang Q, Ye S Technol Health Care. 2024; 32(6):5141-5155.

PMID: 39093101 PMC: 11613086. DOI: 10.3233/THC-241111.


Efficacy of sequential TACE on primary hepatocellular carcinoma with microvascular invasion after radical resection: a systematic review and meta-analysis.

Mo A, Lin B, Chen D World J Surg Oncol. 2023; 21(1):277.

PMID: 37667375 PMC: 10478229. DOI: 10.1186/s12957-023-03160-0.


Effect of PIVKA-II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery.

Cai Y, Xie K, Adeeb Alhmoud M, Lan T, Wan H, Hu D Cancer Med. 2023; 12(17):17866-17877.

PMID: 37596739 PMC: 10523999. DOI: 10.1002/cam4.6422.


Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma.

Yang Z, Hu Z, Fu Y, Hu D, Zhou Z, Chen M J Hepatocell Carcinoma. 2023; 10:1157-1167.

PMID: 37497428 PMC: 10368132. DOI: 10.2147/JHC.S417739.


Contrast-enhanced ultrasound guidance improves the therapeutic efficacy of radiofrequency ablation in liver cancer patients.

Sun Q, Wang A, Chang H Am J Transl Res. 2023; 15(6):3856-3863.

PMID: 37434841 PMC: 10331678.